The lawsuit claims that UnitedHealth Group and its PBM, OptumRx, have been assessing pharmacy DIR fees in violation of federal antitrust laws and state laws governing contracts.
Phenylephrine HCl Injection is indicated for increasing blood pressure in adults with hypotension resulting primarily from vasodilation in the setting of anesthesia.